|
|
|
Dental Care Providers > OralAdvance™ Advantage
|
OralAdvance™ Advantage
|
Use of OralAdvance™ technology gives several
advantages to help dentists with the detection of early-stage
oral cancer.
-
Its role is intended to be complementary to current
standards of care.
-
OralAdvance™ utilizes a virtually painless
soft cyto-brush kit to quickly collect oral mucosa
from suspicious areas.
-
OralAdvance™ facilitates the detection of oral
cancer in its earliest stages by detecting gross
nuclear DNA abnormalities in oral epithelial cells
by utilizing Perceptronix' innovative image
cytometry technology.
Quantitative Cytology Assessment Device
Perceptronix has developed an automated DNA image cytometer
(called ClearCyte™)(
1
) which is designed to analyze slides stained with the
Company's quantitative DNA staining kit. Both products have
received Health Canada approval and the European CE mark
as in-vitro diagnostic medical devices. As opposed to a
conventional stain, the slides are stained specifically
for DNA. This allows a computer-controlled high-resolution
microscope (cytometer) to make measurements of thousands of
cell nuclei and sort them according to their DNA content.
DNA content provides the cytopathologist with an objective
measure of large-scale DNA abnormality and it may indicate
precancerous or cancerous changes in the tissue area sampled.
For more information about OralAdvance™ or to place
an order, call toll-free 1.888.629.8779 or submit an
online order form
.
|
|
|
|